Search clinical trials for: VRC-HIVMAB060-00-AB (VRC01)
Total 108 results
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsUnited States, Puerto Rico, Zimbabwe, South Africa
-
National Institute of Allergy and Infectious Diseases...CompletedMonoclonal Antibody, Human | HIV Antibodies | Neutralizing Antibody | Prevention of HIV InfectionUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsUnited States, South Africa
-
National Institute of Allergy and Infectious Diseases...TerminatedHealthy Adult Immune ResponseUnited States
-
National Institute of Allergy and Infectious Diseases...AIDS Clinical Trials GroupCompleted
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...Not yet recruitingAcute HIV InfectionUnited States, Brazil, Peru
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...AIDS Clinical Trials GroupCompleted
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsSouth Africa, Zimbabwe, Malawi, Botswana, Kenya, Mozambique, Tanzania
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsUnited States, Peru, Brazil, Switzerland
-
National Institute of Allergy and Infectious Diseases...Completed
-
University of California, San FranciscoamfAR, The Foundation for AIDS ResearchRecruitingHIV-1-infectionUnited States
-
National Institute of Allergy and Infectious Diseases...Terminated
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infection | Monoclonal Antibody, Human | HIV Antibodies | VRC01 Monoclonal Antibody | Neutralizing AntibodyUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedHIV-1 Infection | HIV Antibodies | Neutralizing Antibody | Viral Load | Monoclonal AntibodyUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsBotswana, Malawi, Zimbabwe, Brazil
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsUganda, Kenya, Tanzania, Thailand
-
University of North Carolina, Chapel HillNational Institute of Allergy and Infectious Diseases (NIAID)CompletedHIV-1 InfectionUnited States
-
National Institute of Allergy and Infectious Diseases...Active, not recruiting
-
Henry M. Jackson Foundation for the Advancement...US Military HIV Research Program; Janssen Vaccines & Prevention B.V.Not yet recruiting
-
National Institute of Allergy and Infectious Diseases...University of Washington; Harvard School of Public Health (HSPH); Malaria Research... and other collaboratorsCompleted
-
National Institute of Allergy and Infectious Diseases...National Institutes of Health (NIH); University of Washington; Harvard School... and other collaboratorsActive, not recruiting
-
National Institute of Allergy and Infectious Diseases...National Institutes of Health (NIH); University of Washington; Vaccine Research... and other collaboratorsCompleted
-
National Institute of Allergy and Infectious Diseases...Active, not recruitingHIV-1 Infected Adults With Controlled ViremiaUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...Centers for Disease Control and Prevention; International AIDS Vaccine Initiative and other collaboratorsWithdrawn
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...HIV Vaccine Trials NetworkCompleted
-
National Institute of Allergy and Infectious Diseases...United States Department of DefenseCompletedHIV InfectionsUganda, Kenya, Tanzania
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...HIV Vaccine Trials NetworkCompleted
-
National Institute of Allergy and Infectious Diseases...CompletedHealthy Adult Immune Responses to VaccineUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...CompletedHealthy Adult Immune Responses to VaccineUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedRNA Virus Infections | Virus Diseases | Flavivirus Infections | Flaviviridae Infections | Zika Virus Infection | Zika Virus | Flaviviral DiseasesUnited States, Puerto Rico, Mexico, Brazil, Colombia, Costa Rica, Ecuador, Panama, Peru
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | HealthyUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedTrial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy AdultsChikungunya Virus InfectionDominican Republic, Puerto Rico, Guadeloupe, Haiti, Martinique
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | HIV-1 | AIDS VaccinesUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedInnate Immunity | HIV Negative | Adaptive ImmunityUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedEbola Virus Disease | Ebola Vaccines | Marburg Virus Disease | Marburgvirus | EbolavirusUnited States
-
National Institute of Allergy and Infectious Diseases...Completed